IEG Vu is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Pending Chinese Acquisition of Smithfield Foods Raises Lawmaker Questions About Heparin Safety

House Energy and Commerce leaders from the Health and Oversight and Investigations Subcommittees today sent a letter to the President and Chief Executive Office of Smithfield Foods, Inc., C. Larry Pope, requesting information regarding the pending acquisition of the company, with questions spurred by the committee’s ongoing heparin contamination investigation, which dates back to 2008. The pending acquisition of Smithfield Foods raises new concerns regarding the supply of heparin in both the United States and China and the potential threat of contamination, some lawmakers have noted. The letter cites the US company's importance as an ingredient supplier for the blood-thinning drug heparin. Crude heparin is extracted from the intestines of pigs.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts